Evidence map›Paper›PMID 26100635›Full record

ArticleThe Journal of biological chemistry2015

Lipopolysaccharide Phosphorylation by the WaaY Kinase Affects the Susceptibility of Escherichia coli to the Human Antimicrobial Peptide LL-37.

Karol Bociek, Sara Ferluga, Mario Mardirossian, Monica Benincasa, Alessandro Tossi, Renato Gennaro, Marco Scocchi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Karol BociekFrom the Department of Life Sciences, University of Trieste, Via Giorgieri 1, 34127 Trieste, Italy.
Sara FerlugaFrom the Department of Life Sciences, University of Trieste, Via Giorgieri 1, 34127 Trieste, Italy.
Mario MardirossianFrom the Department of Life Sciences, University of Trieste, Via Giorgieri 1, 34127 Trieste, Italy.
Monica BenincasaFrom the Department of Life Sciences, University of Trieste, Via Giorgieri 1, 34127 Trieste, Italy.
Alessandro TossiFrom the Department of Life Sciences, University of Trieste, Via Giorgieri 1, 34127 Trieste, Italy.
Renato GennaroFrom the Department of Life Sciences, University of Trieste, Via Giorgieri 1, 34127 Trieste, Italy.
Marco ScocchiFrom the Department of Life Sciences, University of Trieste, Via Giorgieri 1, 34127 Trieste, Italy mscocchi@units.it.
University of Trieste · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human cathelicidin LL-37 is a multifunctional host defense peptide with immunomodulatory and antimicrobial roles. It kills bacteria primarily by altering membrane barrier properties, although the exact sequence of events leading to cell lysis has not yet been completely elucidated. Random insertion mutagenesis allowed isolation of Escherichia coli mutants with altered susceptibility to LL-37, pointing to factors potentially relevant to its activity. Among these, inactivation of the waaY gene, encoding a kinase responsible for heptose II phosphorylation in the LPS inner core, leads to a phenotype with decreased susceptibility to LL-37, stemming from a reduced amount of peptide binding to the surface of the cells, and a diminished capacity to lyse membranes. This points to a specific role of the LPS inner core in guiding LL-37 to the surface of Gram-negative bacteria. Although electrostatic interactions are clearly relevant, the susceptibility of the waaY mutant to other cationic helical cathelicidins was unaffected, indicating that particular structural features or LL-37 play a role in this interaction.

Indexed as

Gene DeletionAmino Acid SequenceAntimicrobial Cationic PeptidesBlood ProteinsCathelicidinsCell MembraneDrug Resistance, BacterialEscherichia coliEscherichia coli ProteinsGene ExpressionHeptosesHost-Pathogen InteractionsHumansLipopolysaccharidesMicrobial Sensitivity TestsMolecular Sequence DataAntimicrobial Cationic PeptidesBac7(1-35) peptideBlood ProteinsBMAP-27CathelicidinsCRAMP (16-33)Escherichia coli ProteinsHeptosesLipopolysaccharidesPeptide FragmentsProteinsSMAP29 protein, Ovis ariesantimicrobial peptide (AMP)cell permeabilizationlipopolysaccharidelipopolysaccharide (LPS)phosphorylationtransposable element (TE)

Identifiers

PMID26100635
PMCPMC4528152
OpenAlexW1929777163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.